dronabinol and jzl195
dronabinol has been researched along with jzl195 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Vann, RE; Walentiny, DM; Wiley, JL | 1 |
Amin, R; Andrews, MJ; Czyzyk, TA; Davis, BJ; Haskins, CP; Henderson-Redmond, AN; Mackie, K; Marcus, DJ; Morgan, DJ; Zee, ML | 1 |
Other Studies
2 other study(ies) available for dronabinol and jzl195
Article | Year |
---|---|
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Topics: Amidohydrolases; Analysis of Variance; Animals; Arachidonic Acids; Benzodioxoles; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Carbamates; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Glycerides; Male; Mice; Mice, Knockout; Piperazines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rimonabant | 2015 |
Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic.
Topics: Amino Acid Substitution; Animals; Body Weight; Carbamates; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Dronabinol; Eating; Glucose Tolerance Test; Male; Mice, Mutant Strains; Obesity; Piperazines; Receptor, Cannabinoid, CB1 | 2016 |